Zantrene® kills melanoma cancer cells that overproduce FTO
- Written by PR Newswire
- Zantrene® at low concentrations kills high FTO producing melanoma cancer cells
- Sensitivity to Zantrene® correlates with FTO levels, where high FTO producing cells show up to 60x greater sensitivity than low FTO producing cells
- Results are highly supportive of future clinical trials in melanoma using Zantrene® in combination with...
